摘要
目的 探讨人血白蛋白治疗急性脑出血的临床疗效及安全性。方法 急性脑出血患者88例随机分为对照组和治疗组，治疗组在常规治疗基础上加用10％人血白蛋白100ml静脉滴注，1次／d，连用7d。14d为一疗程。比较神经功能缺损程度评分变化。结果 治疗组总有效率及神经功能缺损评分改善情况均优于对照组（P〈0．05），治疗过程中无不良反应发生。结论人血白蛋白治疗急性脑出血临床疗效确切、安全。
Objective To assess the clinical effect and safety of human blood albumin in treatment of acute cerebral hemorrhage. Methods 88 patients with acute cerebral hemorrhage were randomly divided into 2 groups. Both group were given routine therapy and 45 cases in the treating group were given additional 10% human blood albumin 100 ml ivgtt once a day for 7 days. 14 days served as a treatment course. Neurofunction was compared before and after treatment. Results Both the effective rate （ P 〈 0.05 ） and the neurofunction in the treating group were better than that of the control group （ P 〈 0.05 ）. No advert effect happened. Conclusion Human blood albumin is an effective and safe medicine for treatment of acute cerebral infarction.
出处
《中国综合临床》
北大核心
2008年第9期901-902,共2页
Clinical Medicine of China
关键词
急性脑出血
人血白蛋白
临床疗效
Acute cerebral hemorrhage
Human blood albumin
Effect
